Cai Lei - Net Worth and Insider Trading
Cai Lei Net Worth
The estimated net worth of Cai Lei is at least $260,000 dollars as of 2025-04-16. Cai Lei is the Directors, executives of Hybio Pharmaceutical Co Ltd and owns about 20,000 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) stock worth over $260,000. Details can be seen in Cai Lei's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cai Lei has not made any transactions after 2013-06-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Cai Lei
Cai Lei Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cai Lei owns 1 companies in total, including Hybio Pharmaceutical Co Ltd (SZSE:300199) .
Click here to see the complete history of Cai Lei’s form 4 insider trades.
Insider Ownership Summary of Cai Lei
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:300199 | Hybio Pharmaceutical Co Ltd | 2013-06-27 | Directors & executives |
Cai Lei Latest Holdings Summary
Cai Lei currently owns a total of 1 stock. Cai Lei owns 20,000 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) as of June 27, 2013, with a value of $260,000.
Latest Holdings of Cai Lei
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:300199 | Hybio Pharmaceutical Co Ltd | 2013-06-27 | 20,000 | 13.00 | 260,000 |
Holding Weightings of Cai Lei
Cai Lei Form 4 Trading Tracker
According to the SEC Form 4 filings, Cai Lei has made a total of 0 transactions in Hybio Pharmaceutical Co Ltd (SZSE:300199) over the past 5 years. The most-recent trade in Hybio Pharmaceutical Co Ltd is the acquisition of 20,000 shares on June 27, 2013, which cost Cai Lei around $226,200.
Insider Trading History of Cai Lei
- 1
Cai Lei Trading Performance
GuruFocus tracks the stock performance after each of Cai Lei's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cai Lei is 63.86%. GuruFocus also compares Cai Lei's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cai Lei within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cai Lei's insider trading performs compared to the benchmark.
Cai Lei Ownership Network
Ownership Network List of Cai Lei
Ownership Network Relation of Cai Lei

Cai Lei Owned Company Details
What does Hybio Pharmaceutical Co Ltd do?
Who are the key executives at Hybio Pharmaceutical Co Ltd?
Cai Lei is the Directors & executives of Hybio Pharmaceutical Co Ltd. Other key executives at Hybio Pharmaceutical Co Ltd include Directors & Directors & and Executives Zhu Wen Feng , Executives Tao An Jin , and Executives Wei Hong .
Hybio Pharmaceutical Co Ltd (SZSE:300199) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hybio Pharmaceutical Co Ltd (SZSE:300199) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Hybio Pharmaceutical Co Ltd (SZSE:300199)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hybio Pharmaceutical Co Ltd Insider Transactions
Cai Lei Mailing Address
Above is the net worth, insider trading, and ownership report for Cai Lei. Currently GuruFocus does not have mailing address information for Cai Lei.